How many studies have been conducted on Cd40 Ligand?

BiohacksAI has indexed 299 PubMed studies on Cd40 Ligand, including 2 randomized controlled trials (RCTs). 34% of studies involve human subjects.

What are the main research areas for Cd40 Ligand?

The primary research domains for Cd40 Ligand are 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cd40 Ligand

A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1.

299+ PubMed studies analyzed · 2 RCTs · Evidence Score: 47.1

Research Domains

Cd40 Ligand has been studied across 14 research domains including 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity, ❤️ Cardiovascular, 🔥 Metabolic. The primary research focus is 🔬 Inflammation with 27% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd40 Ligand is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.